Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 10, 2016, Pages 1461-1471

  Glatz, Jan F C ^a   Nabben, Miranda ^a   Heather, Lisa C ^b   Bonen, Arend ^c   Luiken, Joost J F P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cardiac ischemia; CD36; Contractile dysfunction; Fatty acid uptake; Insulin resistance; Lipotoxicity; Vesicle associated membrane protein

Indexed keywords

CD36 ANTIGEN; INSULIN; LONG CHAIN FATTY ACID; FATTY ACID;

ARTICLE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; ENDOSOME; FATTY ACID TRANSPORT; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INSULIN RESISTANCE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; SARCOLEMMA; TRANSPORT VESICLE; ANIMAL; CELL FRACTIONATION; CHEMISTRY; HEART CONTRACTION; METABOLISM;

ANIMALS; ANTIGENS, CD36; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; MYOCARDIAL CONTRACTION; MYOCARDIUM; SUBCELLULAR FRACTIONS;

EID: 84966714378     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.04.008     Document Type: Article

References (85)

1. [1] Bing, R.J., Siegel, A., Ungar, I., Gilbert, M., Metabolism of the human heart II. Studies on fat, ketone and amino acid metabolism. Am. J. Med. 16 (1954), 504–515.
2. [2] Stanley, W.C., Recchia, F.A., Lopaschuk, G.D., Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85 (2005), 1093–1129.
3. [3] Unger, R.H., Lipotoxic diseases. Annu. Rev. Med. 53 (2002), 319–336.
4. [4] Wende, A.R., Abel, E.D., Lipotoxicity in the heart. Biochim. Biophys. Acta 1801 (2010), 311–319.
5. [5] Schaap, F.G., Binas, B., Danneberg, H., van der Vusse, G.J., Glatz, J.F.C., Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid-binding protein gene. Circ. Res. 85 (1999), 329–337.
6. [6] Vorum, H., Brodersen, R., Kragh-Hansen, U., Pedersen, A.O., Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim. Biophys. Acta 1126 (1992), 135–142.
7. [7] Richieri, R.V., Kleinfeld, A.M., Unbound free fatty acid levels in human serum. J. Lipid Res. 36 (1995), 229–240.
8. [8] Vork, M.M., Glatz, J.F.C., van der Vusse, G.J., On the mechanisms of long chain fatty acid transport in cardiomyocytes as facilitated by cytoplasmic fatty acid-binding protein. J. Theor. Biol. 160 (1993), 207–222.
9. [9] Glatz, J.F.C., Luiken, J.J.F.P., van Nieuwenhoven, F.A., van der Vusse, G.J., Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 57 (1997), 3–9.
10. [10] Bonen, A., Chabowksi, A., Luiken, J.J.F.P., Glatz, J.F.C., Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical and physiological evidence. Physiology 22 (2007), 15–28.
11. [11] Glatz, J.F.C., Luiken, J.J.F.P., Bonen, A., Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 90 (2010), 367–417.
12. [12] Glatz, J.F.C., Luiken, J.J.F.P., Control of myocardial fatty acid uptake. Lopaschuk, G.D., Dhalla, N.S., (eds.) Cardiac Energy Metabolism in Health and Disease Advances in Biochemistry in Health and Disease, 11, 2014, Springer Publishers, 49–67.
13. [13] Kamp, F., Zakim, D., Zhang, F., Noy, N., Hamilton, J.A., Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 34 (1995), 11928–11937.
14. [14] Zhang, F., Kamp, F., Hamilton, J.A., Dissociation of long and very long fatty acids from phospholipid bilayers. Biochemistry 35 (1996), 16055–16060.
15. [15] Hamilton, J.A., New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 77 (2007), 355–361.
16. [16] Spitsberg, V.L., Matitashvili, E., Gorewit, R.C., Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur. J. Biochem. 230 (1995), 872–878.
17. [17] Abumrad, N.A., El-Maghrabi, M.R., Amri, E.-Z., Lopez, E., Grimaldi, P., Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homol- ogy with human CD36. J. Biol. Chem., 268, 1993 (1993).
18. [18] Stremmel, W., Fatty acid uptake by isolated heart myocytes represents a carrier-mediated transport process. J. Clin. Invest. 81 (1988), 844–852.
19. [19] Schaffer, J.E., Lodish, H.F., Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79 (1994), 427–436.
20. [20] Kazantzis, M., Stahl, A., Fatty acid transport proteins, implications in physiology and diseases. Biochim. Biophys. Acta 1821 (2012), 852–857.
21. [21] Chabowski, A., Górski, J., Luiken, J.J.F.P., Glatz, J.F.C., Bonen, A., Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fat. Acids 77 (2007), 345–353.
22. [22] Habets, D.D.J., Coumans, W.A., Voshol, P.J., den Boer, M.A., Febbraio, M., Bonen, A., Glatz, J.F.C., Luiken, J.J.F.P., AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem. Biophys. Res. Commun. 355 (2007), 204–210.
23. [23] Luiken, J.J.F.P., van Nieuwenhoven, F.A., America, G., van der Vusse, G.J., Glatz, J.F.C., Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: Involvement of sarcolemmal proteins. J. Lipid Res. 38 (1997), 745–758.
24. [24] Luiken, J.J.F.P., Turcotte, L.P., Bonen, A., Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J. Lipid Res. 40 (1999), 1007–1016.
25. [25] Febbraio, M., Silverstein, R.L., CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 39 (2007), 2012–2030.
26. [26] Pepino, M.Y., Kuda, O., Samovski, D., Abumrad, N.A., Structure–function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu. Rev. Nutr. 34 (2014), 281–303.
27. [27] Tahrda, Z., Ibrahimi, A., Insight into the mechanisms of lipids binding and uptake by CD36 receptor. Bioinformation 11 (2015), 302–306.
28. [28] Hoosdally, S.J., Andress, E.J., Wooding, C., Martin, C.A., Linton, K.J., The human scavenger receptor CD36: glycosylation status and its role in trafficking and function. J. Biol. Chem. 284 (2009), 16277–16288.
29. [29] Tao, N., Wagner, S.J., Lublin, D.M., CD36 is palmitolylated on both N- and C-terminal cytoplasmic tails. J. Biol. Chem. 271 (1996), 22315–22320.
30. [30] Silverstein, R.L., Febbraio, M., CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal., 2, 2009, re3.
31. [31] Degrace-Passilly, P., Besnard, P., CD36 and taste of fat. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 107–111.
32. [32] Neculai, D., Schwake, M., Ravichandran, M., Zunke, F., Collins, R.F., Peters, J., Neculai, M., Plump, J., Loppnau, P., Pizarro, J.C., Seitova, A., Trimble, W.S., Saftig, P., Grinstein, S., Dhe-Paganon, S., Structure of LMIP-2 provides functional insights with implications for SR-B1 and CD36. Nature 504 (2013), 172–176.
33. [33] Bonen, A., Luiken, J.J.F.P., Arumugam, Y., Glatz, J.F.C., Tandon, N.N., Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275 (2000), 14501–14508.
34. [34] Luiken, J.J.F.P., Coort, S.L.M., Willems, J., Coumans, W.A., Bonen, A., van der Vusse, G.J., Glatz, J.F.C., Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52 (2003), 1627–1634.
35. [35] Bonen, A., Han, X.-X., Habets, D.D.J., Febbraio, M., Glatz, J.F.C., Luiken, J.J.F.P., A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin-, and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E1740–E1749.
36. [36] Jain, S.S., Chabowski, A., Snook, L.A., Schwenk, R.W., Glatz, J.F.C., Luiken, J.J.F.P., Bonen, A., Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett. 583 (2009), 2294–2300.
37. [37] Chabowski, A., Coort, S.L.M., Calles-Escandon, J., Tandon, N.N., Glatz, J.F.C., Luiken, J.J.F.P., Bonen, A., The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett. 579 (2005), 2428–2432.
38. [38] Chabowski, A., Coort, S.L.M., Calles-Escandon, J., Tandon, N.N., Glatz, J.F.C., Luiken, J.J.F.P., Bonen, A., Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am. J. Physiol. Endocrinol. Metab. 287 (2004), E781–E789.
39. [39] Kerner, J., Hoppel, C., Fatty acid import into mitochondria. Biochim. Biophys. Acta 1486 (2000), 1–17.
40. [40] Bonnefont, J.-P., Djouadi, F., Prip-Buus, C., Gobin, S., Munnich, A., Bastin, J., Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol. Asp. Med. 25 (2004), 495–520.
41. [41] Awan, M.M., Saggerson, E.D., Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem. J. 295 (1993), 61–66.
42. [42] Saddik, M., Gamble, J., Witters, L.A., Lopaschuk, G.D., Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268 (1993), 25836–25845.
43. [43] Eaton, S., Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 41 (2002), 197–239.
44. [44] Carley, A.N., Severson, D.L., What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice?. Cardiovasc. Drugs Ther. 22 (2008), 83–89.
45. [45] Carley, A.N., Atkinson, L.L., Bonen, A., Harper, M.E., Kunnathu, S., Lopaschuk, G.D., Severson, D.L., Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Arch. Physiol. Biochem. 113 (2007), 65–75.
46. [46] Luiken, J.J.F.P., Niessen, H.E., Coort, S.L.M., Hoebers, N.T.H., Coumans, W.A., Schwenk, R.W., Bonen, A., Glatz, J.F.C., Etomoxir-induced partial CPT-I inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem. J. 419 (2009), 447–455.
47. [47] Leto, D., Saltiel, A.R., Regulation of glucose transport by insulin: traffic control of GLUT4. Nat. Rev. Mol. Cell Biol. 13 (2012), 383–396.
48. [48] Klip, A., Sun, Y., Chiu, T.T., Foley, K.P., Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation. Am. J. Physiol. Cell Physiol. 306 (2014), C879–C886.
49. [49] Larance, M., Ramm, G., Stöckli, J., van Dam, E.M., Winata, S., Wasinger, V., Simpson, F., Graham, M., Junutula, J.R., Gulhaus, M., James, D.E., Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J. Biol. Chem. 280 (2005), 37803–37813.
50. [50] Müller, H., Deckers, K., Eckel, J., The fatty acid translocase (FAT)/CD36 and the glucose transporter GLUT4 are localized in different cellular compartments in rat cardiac muscle. Biochem. Biophys. Res. Commun. 293 (2002), 665–669.
51. [51] McMahon, H.T., Mills, I.G., COP and clathrin-coated vesicle budding: different pathways, common approaches. Curr. Opin. Cell Biol. 16 (2004), 379–391.
52. [52] Steinbusch, L.K.M., Wijnen, W., Schwenk, R.W., Coumans, W.A., Hoebers, N.T.H., Ouwens, D.M., Diamant, M., Bonen, A., Glatz, J.F.C., Luiken, J.J.F.P., Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments. Am. J. Physiol. Cell Physiol. 298 (2010), C1549–C1559.
53. [53] Augustus, A.S., Buchanan, J., Addya, S., Rengo, G., Pestell, R.G., Fortina, P., Koch, W.J., Bensadoun, A., Abel, E.D., Lisanti, M.P., Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H657–H666.
54. [54] Satoh, T., Molecular mechanisms for the regulation of insulin-stimulated glucose uptake by small guanosine triphosphatases in skeletal muscle and adipocytes. Int. J. Mol. Sci. 15 (2014), 18677–18692.
55. [55] Samovski, D., Su, X., Xu, Y., Abumrad, N.A., Stahl, P.D., Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a RAB GTPase. J. Lipid Res. 53 (2012), 709–717.
56. [56] Schwenk, R.W., Luiken, J.J.F.P., Eckel, J., FIP2 and Rip11 specify Rab11a-mediated cellular distribution of GLUT4 and FAT/CD36 in H9c2-hIR cells. Biochem. Biophys. Res. Commun. 363 (2007), 119–125.
57. [57] Kawanishi, M., Tamori, Y., Okazawa, H., Araki, S., Shinoda, H., Kasuga, M., Role of SNAP23 in insulin-induced translcoation of GLUT4 in 3 T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J. Biol. Chem. 275 (2000), 8240–8247.
58. [58] Schwenk, R.W., Dirkx, E., Coumans, W.A., Bonen, A., Klip, A., Glatz, J.F.C., Luiken, J.J.F.P., Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53 (2010), 2209–2219.
59. [59] Steinbusch, L.K.M., Schwenk, R.W., Ouwens, D.M., Diamant, M., Glatz, J.F.C., Luiken, J.J.F.P., Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cell. Mol. Life Sci. 68 (2011), 2525–2538.
60. [60] Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Südhof, T.C., Rizo, J., A conformational switch in syntaxin during exocytosis: role of munc18. EMBO J. 18 (1999), 4372–4382.
61. [61] Habets, D.D.J., Thurmond, C., Coumans, W.A., Bonen, A., Glatz, J.F.C., Luiken, J.J.F.P., Munc18c is not rate-limiting for glucose and long-chain fatty acid uptake in the heart. Mol. Cell. Biochem. 322 (2009), 81–86.
62. [62] Jaswal, J.S., Keung, W., Wang, W., Ussher, J.R., Lopaschuk, G.D., Targeting fatty acid and carbohydrate oxidation – a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 1813 (2011), 1333–1350.
63. [63] Opie, L.H., Sack, M.N., Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J. Mol. Cell. Cardiol. 34 (2002), 1077–1089.
64. [64] Heather, L.C., Pates, K.M., Atherton, H.J., Cole, M.A., Ball, D.R., Evans, R.D., Glatz, J.F.C., Luiken, J.J.F.P., Griffin, J.L., Clarke, K., Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion. Circ. Heart Fail. 6 (2013), 1058–1066.
65. [65] Heather, L.C., Cole, M.A., Lygate, C.A., Evans, R.D., Stuckey, D.J., Murray, A.J., Neubauer, S., Clarke, K., Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc. Res. 72 (2006), 430–437.
66. [66] Heather, L.C., Howell, N.J., Emmanuel, Y., Cole, M.A., Frenneaux, M.P., Pagano, D., Clarke, K., Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One, 6, 2011, e26326.
67. [67] Boden, G., Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 (1997), 3–10.
68. [68] Kim, J.K., Fillmore, J.J., Chen, Y., Yu, C., Moore, I.K., Pypaert, M., Lutz, E.P., Kako, Y., Velez-Carrasco, W., Goldberg, I.J., Bresow, J.L., Shulman, G.I., Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 7522–7527.
69. [69] Savage, D.B., Petersen, K.F., Shulman, G.I., Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 (2007), 507–520.
70. [70] Coort, S.L.M., Hasselbaink, D.M., Koonen, D.P.Y., Willems, J., Coumans, W.A., Chabowski, A., van der Vusse, G.J., Bonen, A., Glatz, J.F.C., Luiken, J.J.F.P., Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes, 53(2004), 1655-1663.
71. [71] Ouwens, D.M., Diamant, M., Fodor, M., Habets, D.D., Pelsers, M.M.A.L., El Hanaoui, M., Dang, Z.C., van den Brom, C.E., Vlasblom, R., Rietdijk, A., Boer, C., Coort, S.L.M., Glatz, J.F.C., Luiken, J.J.F.P., Cardiac contractile dysfunction in insulin-resistant rats fed a high fat diet is associated with elevated CD36- mediated fatty acid uptake and esterification. Diabetologia 50 (2007), 1938–1948.
72. [72] Aguer, C., Mercier, J., Man, C.Y., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J.F., Raynaud de Mauverger, E., Andreelli, F., Foretz, M., Kitzmann, M., Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 53 (2010), 1151–1163.
73. [73] Yang, J., Sambandam, N., Han, X., Gross, R.W., Courtois, M., Kovacs, A., Febbraio, M., Finck, B.N., Kelly, D.P., CD36 deficiency rescues lipotoxic cardiomyopathy. Circ. Res. 100 (2007), 1208–1217.
74. [74] Bonen, A., Jain, S.S., Snook, L.A., Han, X.-X., Yoshida, Y., Buddo, K.H., Lally, J.S., Pask, E.D., Paglialunga, S., Beaudoin, M.S., Glatz, J.F.C., Luiken, J.J.F.P., Harasim, E., Wright, D.C., Chabowski, A., Holloway, G.P., Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats. Diabetologia 58 (2015), 2381–2391.
75. [75] Bertrand, L., Ginion, A., Beauloye, C., Hebert, A.D., Guigas, B., Hue, L., Vanoverschelde, J.L., AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H239–H250.
76. [76] Angin, Y., Steinbusch, L.K.M., Simons, P.J., Greulich, S., Hoebers, N.T.H., Douma, K., van Zandvoort, M.A.M.J., Coumans, W.A., Wijnen, W., Diamant, M., Ouwens, D.M., Glatz, J.F.C., Luiken, J.J.F.P., CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem. J. 448 (2012), 43–53.
77. [77] Schwenk, R.W., Angin, Y., Steinbusch, L.K.M., Dirkx, E., Hoebers, N., Coumans, W.A., Bonen, A., Broers, J.L., van Eys, G.J.J.M., Glatz, J.F.C., Luiken, J.J.F.P., Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance. J. Biol. Chem. 287 (2012), 37530–37539.
78. [78] Kuang, M., Febbraio, M., Wagg, C., Lopaschuk, G.D., Dyck, J.R.B., Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 109 (2004), 1550–1557.
79. [79] Nagendran, J., Pulinilkunnil, T., Kienesberger, P.C., Sung, M.M., Fung, D., Febbraio, M., Dyck, J.R.B., Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery. J. Mol. Cell. Cardiol. 63 (2013), 180–188.
80. [80] Sung, M.M., Koonen, D.P.Y., Soltys, C.-L.M., Jacobs, R.L., Febbraio, M., Dyck, J.R.B., Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction. J. Mol. Med. 89 (2011), 459–469.
81. [81] Steinbusch, L.K.M., Luiken, J.J.F.P., Vlasblom, R., Chabowski, A., Hoebers, N.T.H., Coumans, W.A., Vroegrijk, I.O.C.M., Voshol, P.J., Ouwens, D.M., Glatz, J.F.C., Diamant, M., Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E618–E628.
82. [82] Zhang, Y., Bao, M., Dai, M., Wang, X., He, W., Tan, T., Lin, D., Wang, W., Wen, Y., Zhang, R., Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice. Cardiovasc. Diabetol., 14, 2015, 69.
83. [83] Coort, S.L.M., Willems, J., Coumans, W.A., van der Vusse, G.J., Bonen, A., Glatz, J.F.C., Luiken, J.J.F.P., Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol. Cell. Biochem. 239 (2002), 213–219.
84. [84] Lauzier, B., Merlen, C., Vaillant, F., McDuff, J., Bouchard, B., Beguin, P.C., Dolinsky, V.W., Foisy, S., Villeneuve, L.R., Labarthe, F., Dyck, J.R., Allen, B.G., Charron, G., Des Rosiers, C., Post-translocational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J. Mol. Cell. Cardiol. 51 (2011), 99–108.
85. [85] Kim, K.-Y., Stevens, M.V., Akter, M.H., Rusk, S.E., Huang, R.J., Cohen, A., Noguchi, A., Springer, D., Bocharov, A.V., Eggerman, T.L., Suen, D.-F., Youle, R.J., Amar, M., Remaley, A.T., Sack, M.N., Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J. Clin. Invest. 121 (2011), 3701–3712.